Thromboprophylaxis in Acutely Ill Medical Patients: Results of A Survey Among Italian Physicians

被引:3
|
作者
Dentali, Francesco [1 ]
Pomero, Fulvio [2 ]
La Regina, Micaela [3 ]
Orlandini, Francesco [3 ]
Turato, Sara [1 ]
Mazzone, Antonino [4 ]
Nozzoli, Carlo [5 ]
Fontanella, Andrea [6 ]
Ageno, Walter [1 ]
Agnelli, Giancarlo [7 ]
Campanini, Mauro [8 ]
机构
[1] Insubria Univ, Dept Clin Med, I-21100 Varese, Italy
[2] ASO S Croce E Carle, Dept Clin Med, Cuneo, Italy
[3] Presidio Ospedaliero Unico Levante Ligure, Dept Internal Med, La Spezia, Italy
[4] AO Osped Civile, Dept Internal Med, Legnano, Italy
[5] AO Careggi, Dept Internal Med, Florence, Italy
[6] Osped Buon Consiglio, Dept Internal Med, Naples, Italy
[7] Univ Perugia, Internal & Cardiovasc Med & Stroke Unit, I-06100 Perugia, Italy
[8] AOU Maggiore Carita, Dept Internal Med, Novara, Italy
关键词
venous thromboembolism; bleeding risk; thromboprophylaxis; RAMs; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM PROPHYLAXIS; RANDOMIZED CONTROLLED-TRIAL; ACUTE ISCHEMIC-STROKE; BLEEDING RISK; PREVENTION; ENOXAPARIN; COMPRESSION; MULTICENTER; VALIDATION;
D O I
10.1016/j.thromres.2014.06.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: acutely ill medical patients are at increased risk of venous thromboembolism (VTE) and often require thromboprophylaxis, but patient selection and adequate therapeutic decisions may be difficult due to the heterogeneity and the complexity of this population. We conducted a survey among a large cohort of Italian physicians to assess their approach to some important "grey" areas of VTE prevention in this setting. Methods: a questionnaire was distributed during the meeting of a national society of Internal Medicine (FADOI), held in May 2013. Four clinical scenarios describing areas of clinical uncertainty were administered to participants: the first on a patient with acute ischemic stroke; the second on a patient with severe renal insufficiency; the third on the duration of prophylaxis in the post-acute setting; and the last on a patient at high risk of VTE and at moderate risk of bleeding with preserved mobility. Results: 453 questionnaires were returned (participants mean age 48.5 years). About 70% of participants systematically assess VTE and bleeding risk in their clinical practice, but a minority of them use risk assessment models. Prolonged prophylaxis in the post-acute setting was voted by more than eighty percent of participants; replies to the other three clinical scenarios were more heterogeneous with none of the options selected by more than 60% of participant. Conclusion: physicians approach to "grey" areas of antithrombotic prophylaxis in the medical setting is quite heterogeneous and sometimes partially in contrast to recent guidelines, reinforcing the need for educational programs and high quality studies in this setting. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 50 条
  • [1] Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
    Cohen, Alexander T.
    Spiro, Theodore E.
    Buller, Harry R.
    Haskell, Lloyd
    Hu, Dayi
    Hull, Russell
    Mebazaa, Alexandre
    Merli, Geno
    Schellong, Sebastian
    Spyropoulos, Alex C.
    Tapson, Victor
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (06) : 513 - 523
  • [2] Pharmacological Thromboprophylaxis in Acutely Ill Hospitalized Medical Patients
    Kantor, B.
    Poenou, G.
    Plaisance, L.
    Toledano, E.
    Mekhloufi, Y.
    Helfer, H.
    Djennaoui, S.
    Mahe, I.
    REVUE DE MEDECINE INTERNE, 2022, 43 (01): : 9 - 17
  • [3] Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
    Cohen, Alexander T.
    Harrington, Robert A.
    Goldhaber, Samuel Z.
    Hull, Russell D.
    Wiens, Brian L.
    Gold, Alex
    Hernandez, Adrian F.
    Gibson, C. Michael
    Cohen, Alexander
    Harrington, Robert
    Gibson, C. Michael
    Hull, Russell
    Goldhaber, Samuel
    Hernandez, Adrian
    Ceresetto, Jose Manuel
    Colquhoun, David
    Pilger, Ernst
    Polonetsky, Leonid
    Motte, Serge
    Saraiva, Jose Francisco
    Raev, Dimitar
    Mincheva, Valentina
    Kahn, Susan
    Canon, Claudia Olivares
    Malojcic, Branko
    Mayer, Otto
    Husted, Steen
    Marandi, Toomas
    Lassila, Riitta
    Mottier, Dominique
    Shaburishvili, Tamaz
    Bauersachs, Rupert
    Zeymer, Uwe
    Hajko, Erik
    Zeltser, David
    Ageno, Walter
    Krievins, Dainis
    Bagdonas, Alfredas
    Osores, Juan Lema
    Tomkowski, Witold
    Mot, Stefan
    Panchenko, Elizaveta
    Tan, Ru San
    Gaspar, Ludovit
    Jacobson, Barry
    Monreal, Manuel
    Ongen, Gul
    Parkhomenko, Alexander
    Uprichard, James
    Yusen, Roger
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (06) : 534 - 544
  • [4] Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol
    Cohen, Alexander Thomas
    Spiro, Theodore Erich
    Buller, Harry Roger
    Haskell, Lloyd
    Hu, Dayi
    Hull, Russell
    Mebazaa, Alexandre
    Merli, Geno
    Schellong, Sebastian
    Spyropoulos, Alex
    Tapson, Victor
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (04) : 407 - 416
  • [5] Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis
    Chi, G.
    Goldhaber, S. Z.
    Kittelson, J. M.
    Turpie, A. G. G.
    Hernandez, A. F.
    Hull, R. D.
    Gold, A.
    Curnutte, J. T.
    Cohen, A. T.
    Harrington, R. A.
    Gibson, C. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (10) : 1913 - 1922
  • [6] The benefit of betrixaban for the extended thromboprophylaxis in acutely ill medical patients
    Scarpa, Daniele
    Denas, Gentian
    Babuin, Luciano
    Pengo, Vittorio
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (03) : 261 - 268
  • [7] The risk of stroke among acutely ill hospitalized medical patients: lessons from recent trials on extended-duration thromboprophylaxis
    Marszalek, Jolanta
    Mehrsefat, Sara
    Chi, Gerald
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (08) : 679 - 684
  • [8] Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?
    Turpie, A. G. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (01) : 5 - 11
  • [9] Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older
    Ageno, Walter
    Lopes, Renato D.
    Goldin, Mark
    Yusen, Roger D.
    Albers, Gregory W.
    Elliott, Gregory C.
    Halperin, Jonathan L.
    Hiatt, William R.
    Maynard, Gregory
    Steg, Philippe Gabriel
    Weitz, Jeffrey, I
    Suh, Eunyoung
    Lu, Wentao
    Barnathan, Elliot S.
    Raskob, Gary E.
    Spyropoulos, Alex C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (11) : 2772 - 2780
  • [10] Venous thromboembolism prophylaxis of acutely ill hospitalized medical patients. Are we under-treating our patients?
    Roth-Yelinek, Batia
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (03) : 236 - 239